39 studies found for:    Open Studies | "Telangiectasis"
Show Display Options
Rank Status Study
21 Unknown  Topical Bevacizumab for the Management of Recurrent Epistaxis in Patients With Hereditary Hemorrhagic Telangiectasia (HHT)
Condition: Hereditary Hemorrhagic Telangiectasia (HHT)
Intervention: Drug: Bevacizumab
22 Recruiting Topical Brimonidine to Reduce Inflammation After IPL-treatment in Patients With Facial Telangiectasias
Condition: Telangiectasias
Interventions: Drug: Brimonidine;   Other: IPL+air-cooling
23 Recruiting Oxidative Stress, Low Grade Inflammation, Tissue Breakdown and Biomarkers in Cerebrospinal Fluid of A-T
Condition: Ataxia Telangiectasia
Intervention: Procedure: Lumbar puncture
24 Unknown  Investigation of Plasma Proteins in Patients With Hereditary Haemorrhagic Telangiectasia and PAVMs
Condition: Telangiectasia, Hereditary Hemorrhagic
Intervention:
25 Unknown  Enhanced Safety Aesthetic Laser System
Conditions: Hirsutism;   Hypertrichosis;   Telangiectases;   Rhytides
Intervention: Device: Peterio
26 Not yet recruiting Prospective Pilot Study of Floseal for the Treatment of Anterior Epistaxis in Patients With (HHT)
Conditions: Hereditary Hemorrhagic Telangiectasia (HHT);   Epistaxis
Interventions: Drug: Floseal;   Other: Packing
27 Recruiting Intranasal Bevacizumab for HHT-Related Epistaxis
Conditions: HHT;   Hereditary Hemorrhagic Telangiectasia;   Epistaxis;   Nose Bleeds;   Nasal Bleeding
Interventions: Drug: Bevacizumab;   Drug: Placebo (Saline)
28 Recruiting Pancreatic Cancer Screening of High-Risk Individuals in Arkansas
Conditions: Pancreatic Neoplasms;   Peutz-Jegher's Syndrome;   BRCA1 Gene Mutation;   BRCA2 Gene Mutation;   Ataxia Telangiectasia;   Familial Atypical Mole-Malignant Melanoma Syndrome;   Colorectal Neoplasms, Hereditary Nonpolyposis;   Hereditary Pancreatitis
Interventions: Other: Pancreatic Cancer Screening Pathway 1;   Other: Pancreatic Cancer Screening Pathway 2
29 Unknown  Studies of White Blood Cells Derived From HHT Patients
Condition: Telangiectasia, Hereditary Hemorrhagic
Intervention:
30 Not yet recruiting EDS in Ataxia Telangiectasia Patients
Conditions: Nervous System Disease;   Genetic Disease;   Rare Disease
Interventions: Drug: EDS-EP dose range of ~5-10 mg DSP/infusion;   Drug: EDS-EP dose range of ~14-22 mg DSP/infusion;   Drug: Placebo
31 Not yet recruiting Octreotide in Patients With GI Bleeding Due to Rendu-Osler-Weber
Conditions: Hereditary Hemorrhagic Telangiectasia;   Gastrointestinal Hemorrhage;   Anemia
Intervention: Drug: Octreotide LAR
32 Not yet recruiting Cardiopulmonary Exercise Testing to Evaluate Pulmonary AVMs With and Without Airflow Obstruction
Conditions: Pulmonary Arteriovenous Malformations;   Hereditary Hemorrhagic Telangiectasia;   Asthma;   COPD
Intervention: Other: Cardiopulmonary exercise test
33 Recruiting Cardiopulmonary Exercise Testing to Evaluate Pulmonary AVMs
Conditions: Pulmonary Arteriovenous Malformations;   Hereditary Hemorrhagic Telangiectasia
Interventions: Other: Cardiopulmonary exercise test;   Procedure: Blood test
34 Recruiting Genetic Factors of Idiopathic Polypoidal Vasculopathies in the ATM Gene (Ataxia Telangiectasia Mutated)
Condition: Choroidal Neovascularization
Intervention:
35 Unknown  Endpoint Management Software for Photothermal Stimulation of Macular Diseases
Conditions: Diabetic Macular Edema;   Branch Retinal Vein Occlusion;   Chronic Central Serous Retinopathy;   Macular Telangiectasia
Intervention: Procedure: Topcon Endpoint Management
36 Unknown  Transversalis Fascial Plane Nerve Block in Iliac Crest Bone Graft
Conditions: Upper Limb Surgery;   Iliac Crest Bone Harvest
Interventions: Drug: Active treatment;   Drug: Placebo Arm
37 Recruiting Rare Disease Patient Registry: Coordination of Rare Diseases at Sanford
Conditions: Rare Disorders;   Undiagnosed Disorders;   Disorders of Unknown Prevalence;   Cornelia De Lange Syndrome
Intervention:
38 Recruiting Mast Cell Connect: A Registry for Patients With Mastocytosis
Condition: Mastocytosis
Intervention:
39 Recruiting Reperfusion of Pulmonary Arteriovenous Malformations After Embolotherapy
Condition: Pulmonary Arteriovenous Malformations
Intervention: Procedure: Angiography and embolotherapy

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-39) Next Page   
Indicates status has not been verified in more than two years